LGALS3 and neoplasm: In C2GNT1-expressing tumor cells, GAL-3 was demonstrated to bind to core two O-glycans present in major histocompatibility complex class I-related chain A (MICA), which impeded ligand binding to NKG2D and subsequent NK cell activation and tumor destruction (150).